HomeAblaCor Medical Corporation

AblaCor Medical Corporation

USPTO Allows AblaCor™ Five Ablation Catheter-Anchoring Patents for its CircumBlator™ AF Catheter Ablation System

3/5/18: AblaCor Medical Corporation announced today that it has received a notice of allowance from the United States Patent & Trademark Office on five additional patents for its CircumBlator™ AFib Catheter Ablation System to advance pulmonary vein isolation ablation procedures for patients with atrial fibrillation, the most common irregular heart rhythm and a potentially deadly disorder.